Feb 05, 2013 09:00 GMT BioProcess International Europe Conference and Exhibition Jan. 30 (Bloomberg) -- Pfizer Inc., the world’s largest drugmaker, may consider dividing its branded medicines and generic products units into separate businesses, Chief Executive Officer Ian Read said.






